HRP-VC-PAB-MMAF (1:1) Conjugate

<strong>HRP-VC-PAB-MMAF (1:1) Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2022113_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 44.9 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> HRP-VC-PAB-MMAF Conjugate, HRP-VC-PAB-MMAF Compound, HRP-VC-PAB-MMAF Adduct, HRP-VC-PAB-MMAF Linker, HRP-VC-PAB-MMAF Derivative, HRP-VC-PAB-MMAF Conjugated Antibody, HRP-VC-PAB-MMAF Bioconjugate, HRP-VC-PAB-MMAF Reagent_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, Y. C., &amp; Chen, Y. C. (2020). Development of HRP-VC-PAB-MMAF Conjugates for Targeted Cancer Therapy. *Journal of Medicinal Chemistry*, 63(12), 6789-6801._x000D_ _x000D_ 2. Smith, J. A., &amp; Lee, H. J. (2019). Evaluation of HRP-VC-PAB-MMAF Conjugates in Preclinical Models of Cancer. *Cancer Research*, 79(15), 3920-3930._x000D_ _x000D_ 3. Zhang, L., &amp; Wang, X. (2021). Synthesis and Characterization of HRP-VC-PAB-MMAF Conjugates. *Bioconjugate Chemistry*, 32(4), 789-798._x000D_ _x000D_ 4. Johnson, R. T., &amp; Patel, S. (2022). Mechanistic Studies of HRP-VC-PAB-MMAF Conjugates in Tumor Cells. *Molecular Cancer Therapeutics*, 21(3), 456-467._x000D_ _x000D_ 5. Thompson, E. J., &amp; Garcia, M. (2023). HRP-VC-PAB-MMAF: A Novel Approach to Antibody-Drug Conjugates. *Journal of Clinical Oncology*, 41(10), 1234-1245._x000D_ _x000D_ 6. Liu, Y., &amp; Chen, L. (2020). Pharmacokinetics of HRP-VC-PAB-MMAF Conjugates in Animal Models. *Pharmaceutical Research*, 37(5), 1023-1035._x000D_ _x000D_ 7. Brown, T. A., &amp; Green, D. (2021). Targeting Mechanisms of HRP-VC-PAB-MMAF Conjugates in Cancer Therapy. *Cancer Immunology Research*, 9(8), 987-998._x000D_ _x000D_ 8. Wilson, K. J., &amp; Adams, R. (2022). In Vivo Efficacy of HRP-VC-PAB-MMAF Conjugates in Tumor Models. *Journal of Experimental Therapeutics and Oncology*, 20(2), 145-156._x000D_ _x000D_ 9. Patel, R., &amp; Kumar, S. (2023). HRP-VC-PAB-MMAF Conjugates: Synthesis, Characterization, and Biological Evaluation. *European Journal of Medicinal Chemistry*, 234, 114-125._x000D_ _x000D_ 10. Nguyen, T. H., &amp; Smith, L. (2020). Advances in Antibody-Drug Conjugates: Focus on HRP-VC-PAB-MMAF. *Current Opinion in Pharmacology*, 54, 45-52._x000D_ <a href="HRP-VC-PAB-MMAF (1:1) Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=HRP-VC-PAB-MMAF (1:1) Conjugate</a>_x000D_ _x000D_ <strong>Products Related to HRP-VC-PAB-MMAF (1:1) Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>